Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model.
about
Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Bevacizumab-mediated tumor vas ...... uroblastoma preclinical model.
@en
Bevacizumab-mediated tumor vas ...... uroblastoma preclinical model.
@nl
type
label
Bevacizumab-mediated tumor vas ...... uroblastoma preclinical model.
@en
Bevacizumab-mediated tumor vas ...... uroblastoma preclinical model.
@nl
prefLabel
Bevacizumab-mediated tumor vas ...... uroblastoma preclinical model.
@en
Bevacizumab-mediated tumor vas ...... uroblastoma preclinical model.
@nl
P2093
P2860
P50
P1433
P1476
Bevacizumab-mediated tumor vas ...... uroblastoma preclinical model.
@en
P2093
Annalisa Pezzolo
Concetta Quintarelli
Emma Di Carlo
Ignazia Prigione
Laura Emionite
Michele Cilli
Paola Bocca
Vito Pistoia
P2860
P304
P356
10.1080/2162402X.2017.1378843
P577
2017-10-04T00:00:00Z